Authors’ reply to Datta | The BMJ

Researchers from McMaster University and the University of British Columbia in Canada have found an association between race or ethnicity and obstetric anal sphincter injury (OASI). Studies have shown that Asian women in high income countries such as Australia, Canada, Norway, the United Kingdom, and the United States have higher rates of OASI, 1.5 to…

Read More

Vagina Size and Sexual Pleasure: Does Size Matter?

The size of a woman’s vagina and its impact on sexual pleasure have been debated, with limited research on the topic. Vaginas are highly elastic and can change in size to accommodate different activities such as childbirth and sexual arousal. Women may experience discomfort during sex due to factors such as muscular weakness or injury,…

Read More

How Common Is It in Patients on Dupilumab?

A study found that 2% of patients taking dupilumab for atopic dermatitis (AD) are likely to experience conjunctivitis, with occurrences happening most frequently within the first 16 weeks of therapy. Developed for AD treatment, dupilumab inhibits signaling of interleukin (IL)-4 and IL-13, found in inflammatory diseases like AD, asthma, and others. In a study of…

Read More

An Alternative Approach To Treat Obesity? Scientists Develop Vibrating, Ingestible Capsule That Makes You Feel Full

Researchers have developed an ingestible capsule that vibrates in the stomach to create a sense of fullness and reduce food intake by about 40%. The capsule was tested on animals and found to stimulate the release of hormones that signal satiety. When vibrating, hormone levels closely mimicked patterns seen after eating. The current version of…

Read More

Health Bulletin 30/December/2023

The health bulletin for 30th December 2023 discusses the use of cookies for analytics, advertising, and site improvement. Users are asked to agree to the use of cookies by continuing to use the site. Further information about the use of cookies can be found in the Cookie Policy and Cookie Settings. Source link

Read More

PERSEUS trial results ‘practice-changing’ for newly diagnosed multiple myeloma

The article discusses the results of the phase 3 PERSEUS trial presented at ASH 2023. The trial showed that daratumumab combined with bortezomib, lenalidomide, and dexamethasone is more effective than the latter three drugs alone in treating newly diagnosed multiple myeloma patients. Chakra Chaulagain, MD, director of the myeloma and amyloidosis program at Cleveland Clinic…

Read More
error: Content is protected !!